Patient perspective

Rare diseases under different levels of economic analysis: current activities, challenges and perspectives
Sara Cannizzo, Valentina Lorenzoni, Ilaria Palla, Salvatore Pirri, Leopoldo Trieste, Isotta Triulzi, Giuseppe Turchetti

RMD Open Nov 2018, 4 (Suppl 1) e000794; DOI: 10.1136/rmdopen-2018-000794
Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy
Johanna Callhoff, Katinka Albrecht, Georg Schett, Angela Zink, Gisela Westhoff

RMD Open Feb 2015, 1 (1) e000020; DOI: 10.1136/rmdopen-2014-000020
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools
Piet van Riel, Rieke Alten, Bernard Combe, Diana Abdulganieva, Paola Bousquet, Molly Courtenay, Cinzia Curiale, Antonio Gómez-Centeno, Glenn Haugeberg, Burkhard Leeb, Kari Puolakka, Angelo Ravelli, Bernhard Rintelen, Piercarlo Sarzi-Puttini

RMD Open Nov 2016, 2 (2) e000302; DOI: 10.1136/rmdopen-2016-000302
Identifying a core set of outcome domains to measure in clinical trials for shoulder disorders: a modified Delphi study
Matthew J Page, Hsiaomin Huang, Arianne P Verhagen, Rachelle Buchbinder, Joel J Gagnier

RMD Open Dec 2016, 2 (2) e000380; DOI: 10.1136/rmdopen-2016-000380
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
Vibeke Strand, Eun Bong Lee, Roy Fleischmann, Rieke E Alten, Tamas Koncz, Samuel H Zwillich, David Gruben, Bethanie Wilkinson, Sriram Krishnaswami, Gene Wallenstein

RMD Open Sep 2016, 2 (2) e000308; DOI: 10.1136/rmdopen-2016-000308
Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis
Isabel Castrejón, Theodore Pincus, Daniel Wendling, Maxime Dougados

RMD Open Jul 2016, 2 (2) e000235; DOI: 10.1136/rmdopen-2015-000235
Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
Jos Hendrikx, Marieke J de Jonge, Jaap Fransen, Wietske Kievit, Piet LCM van Riel

RMD Open Aug 2016, 2 (2) e000202; DOI: 10.1136/rmdopen-2015-000202
Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohort
C Lukas, M Dougados, B Combe

RMD Open Feb 2016, 2 (1) e000204; DOI: 10.1136/rmdopen-2015-000204
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial
Karen Hambardzumyan, Rebecca J Bolce, Saedis Saevarsdottir, Kristina Forslind, Johan K Wallman, Scott E Cruickshank, Eric H Sasso, David Chernoff, Ronald F van Vollenhoven

RMD Open Mar 2016, 2 (1) e000197; DOI: 10.1136/rmdopen-2015-000197
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis
Roy Fleischmann, Vibeke Strand, Bethanie Wilkinson, Kenneth Kwok, Eustratios Bananis

RMD Open Apr 2016, 2 (1) e000232; DOI: 10.1136/rmdopen-2015-000232

Main menu

Patient perspective

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Patient perspective

Pages